Clinical parameters (total subjects: 79) PCa (41) BPH (38)
Median Age 65 (54-75) 66 (48-74)
Median PSA (ng/mL) 7.32 (3.54-50) 7.24 (1.38-21.22)
Clinical Gleason Score 6 (3+3) 32 -
7 (3+4) 6
7 (4+3) 1
8 (4+4) 1
9 (5+4) 1
Clinical staging cT1c 23
cT2a 13
cT2c 3
cT3a 2
Pathological Gleason Score 6 (3+3) 29 -
7 (3+4) 9
7 (4+3) 1
8 (4+4) 1
10 (5+5) 1
Pathological Staging pT2a 4
pT2c 28
pT3a 6
pT3b 3
Positive Surgical Margin 15% -
Table 1: Clinical parameters of subjects included in the study.